Financhill
Back

EyePoint Pharmaceuticals Stock Price Chart

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EYPT is experiencing slight buying pressure.

EyePoint Pharmaceuticals Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 9.31 Sell
20-day SMA: 10.76 Sell
50-day SMA: 9.77 Sell
200-day SMA: 13.45 Sell
8-day EMA: 9.35 Sell
20-day EMA: 10.02 Sell
50-day EMA: 9.94 Sell
200-day EMA: 11.46 Sell

EyePoint Pharmaceuticals Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.37 Sell
Relative Strength Index (14 RSI): 41.34 Sell
Chaikin Money Flow: 378625 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (9.4 - 11.84) Sell
Bollinger Bands (100): (8.13 - 10.51) Sell

EyePoint Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for EyePoint Pharmaceuticals Stock

Is EyePoint Pharmaceuticals Stock a Buy?

EYPT Technical Analysis vs Fundamental Analysis

Buy
61
EyePoint Pharmaceuticals (EYPT) is a Buy

Is EyePoint Pharmaceuticals a Buy or a Sell?

EyePoint Pharmaceuticals Stock Info

Market Cap:
610.85M
Price in USD:
8.95
Share Volume:
1.1M

EyePoint Pharmaceuticals 52-Week Range

52-Week High:
30.99
52-Week Low:
5.87
Buy
61
EyePoint Pharmaceuticals (EYPT) is a Buy

EyePoint Pharmaceuticals Share Price Forecast

Is EyePoint Pharmaceuticals Stock a Buy?

Fundamental Analysis of EyePoint Pharmaceuticals

Is EyePoint Pharmaceuticals a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.31 per share, and a decrease next year of $0.31 per share.

Technical Analysis of EyePoint Pharmaceuticals

Should I short EyePoint Pharmaceuticals stock?

* EyePoint Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.